胸主动脉覆膜支架在主动脉缩窄中诱导持续主动脉重塑
回顾性研究纳入30例接受胸主动脉覆膜支架治疗的成人主动脉缩窄患者,平均年龄46.5岁,53.3%既往未接受治疗。中位随访979天,1例死亡,所有患者症状完全缓解且无复发。支架置入显著降低缩窄处压差(P < 0.0001),缩窄段直径在术后30天显著增加并持续至5年,3年以上可见缩窄部位及周围区域主动脉重塑,血压在30天及1年时持续改善。
要点
- 胸主动脉覆膜支架显著降低主动脉缩窄处压差(P < 0.0001)。
- 缩窄段直径在术后30天显著增加,并持续增加至治疗后5年。
- 随访3年以上可见缩窄部位及周围区域主动脉重塑。
核心结论
- 覆膜支架是治疗主动脉缩窄安全有效的方法。
- 观察到血压临床显著改善及缩窄段和整个主动脉的纵向重塑,持续超过3年。
研究设计与样本
- 回顾性研究,纳入30例在本机构接受胸主动脉覆膜支架治疗的成人主动脉缩窄患者。
- 平均年龄46.5岁,53.3%的患者既往未接受缩窄治疗或修复。
- 修复指征包括压差 ≥20 mm Hg 且影像学有缩窄解剖证据,并伴左心室肥厚、假性动脉瘤、动脉瘤、难治性高血压或跛行。
- 使用的覆膜支架包括 MDT(Medtronic, Santa Rosa, CA)和 GORE TAG(W. L. Gore & Associates, Flagstaff, AZ)。
主要发现
- 患者中位随访979天,研究期间1例死亡。
- 所有患者症状完全缓解,无复发。
- 胸主动脉腔内修复显著降低缩窄处压差(P < 0.0001)。
- 缩窄段主动脉直径在术后30天显著增加,并持续增加至治疗后5年。
- 治疗后3年以上,在缩窄部位及周围区域观察到主动脉重塑。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study's objective is to describe outcomes of adult patients who underwent thoracic stent graft placement treatment for primary or recurrent aortic coarctation. METHODS: This is a retrospective study of 30 adult patients who underwent thoracic stent graft placement for aortic coarctation at our institution. Average age was 46.5 years, with 53.3% of patients presented with no prior treatment or repair for coarctation. Indications for repair included gradient ≥20 mm Hg with anatomic evidence of coarctation on imaging with left ventricular hypertrophy, pseudoaneurysm, aneurysm, refractory hypertension, or claudication. Stent grafts used for repair included MDT (Medtronic, Santa Rosa, CA) and GORE TAG (W. L. Gore & Associates, Flagstaff, AZ). RESULTS: Patients were observed for a median of 979 days, with one death during the study. All patients had complete resolution of symptoms with no recurrences. Thoracic endovascular aortic repair significantly reduced the gradient across the coarctation (P < 0.0001). Aortic coarctation diameter significantly increased at 30 days postoperatively and continued to increase up to 5 years posttreatment. At 3+ years, aortic remodeling was observed at the coarctation site and surrounding regions. At 30 days, systolic, diastolic, and mean arterial pressure were all reduced. Systolic and diastolic blood pressure and mean arterial pressure continued to significantly improve 1-year posttreatment. CONCLUSIONS: Stent grafts are a safe and effective treatment for aortic coarctation. We observed a clinically significant improvement in blood pressure and longitudinal aortic remodeling of the coarctation segment and the entire aorta that persisted more than more than 3 years.
引用
- Yammine H, Frederick JR, Alegria J, et al. Thoracic Stent Grafts Induce Persistent Aortic Remodeling in Aortic Coarctation. Ann Vasc Surg. 2024. PMID: 38838987. doi:10.1016/j.avsg.2024.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。